Neurovative Diagnostics, a leader in advanced neurodiagnostic services, is pleased to announce a new partnership with UnitedHealthcare (UHC). As an in-network provider for all UHC products, including Commercial, Medicare, and Medicaid plans, Neurovative Diagnostics is now accessible to UnitedHealthcare members across the country, expanding options for innovative and precise diagnostic solutions.
This collaboration enables eligible UHC members to benefit from Neurovative Diagnostics’ extensive expertise in delivering high quality diagnostic services, which are crucial for effective patient care and management. By becoming an in-network provider, Neurovative Diagnostics aims to reduce barriers, streamline access to services, and enhance the overall healthcare experience for UHC members.
“We are excited to partner with UnitedHealthcare to enhance the accessibility of our specialized diagnostic services,” said Tony Wax, CEO of Neurovative Diagnostics. “Our objective is to equip healthcare providers with timely, accurate diagnostic data to improve patient care. Joining UHC’s network aligns with our mission of providing outstanding, innovative care while upholding our values of integrity and service excellence, ultimately supporting enhanced patient outcomes.”
Starting immediately, Neurovative Diagnostics is able to provide in-network scheduling for diagnostic services ordered by physicians, making it easier for UnitedHealthcare members across various plans to access essential neurodiagnostic care.
For more information or to find out if you are eligible to benefit from this new in-network status, please contact us on info@neurovativediagnostics.com